Mid-Afternoon Market Update: Dow Jumps 190 Points; Altimmune Shares Plummet
Toward the end of trading Wednesday, the Dow traded up 0.55% to 34,482 while the NASDAQ fell 0.22% to 14,496.86. The S&P also rose, gaining 0.04% to 4,293.57.
Mid-Day Market Update: Barnes & Noble Education Drops Following Q4 Results; Aerovate Therapeutics Shares Surge
Midway through trading Wednesday, the Dow traded up 0.42% to 34,437.23 while the NASDAQ fell 0.14% to 14,508.18. The S&P also rose, gaining 0.06% to 4,294.30.
B. Riley Securities Maintains Buy on Altimmune, Lowers Price Target to $21
B. Riley Securities analyst Mayank Mamtani maintains Altimmune (NASDAQ:ALT) with a Buy and lowers the price target from $41 to $21.
10 Biggest Price Target Changes For Wednesday
Wells Fargo raised the price target for Occidental Petroleum Corporation (NYSE: OXY) from $28 to $34. Occidental Petroleum shares rose 1.3% to $31.70 in pre-market trading.
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)
29 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Bridgeline Digital, Inc. (NASDAQ: BLIN) shares rose 83% to $6.20 in pre-market trading. Bridgeline Digital shares jumped over 36% on Tuesday on above-average volume.
JMP Securities Maintains Market Outperform on Altimmune, Lowers Price Target to $31
JMP Securities analyst Jonathan Wolleben maintains Altimmune (NASDAQ:ALT) with a Market Outperform and lowers the price target from $53 to $31.